Wilmington Investor Network

Wilmington Investor Network is a private equity fund of angel investors.

Business Model:

Revenue: $6.3M

Employees: 2-10

Rankings

Industries / Tags:

Detailed Wilmington Investor Network Information

Geographic Data

Wilmington Investor Network headquarters map

Address: 1802 S Churchill Dr

City: Wilmington

State: NC

Zip: 28403

Country: US

Financial Info

Stage:

Raised Last:

$0

Raised Total:

$0

Metrics

0Website Global Rank

0Website Monthly Traffic

Twitter Followers

Description

Wilmington Investor Networks is a private equity firm that invests in technology, insurances and media companies.

Contact Phone:
+19105386641

Contact Email:

Announced Date Company Transaction Money Raised
5/2014 Trusted Metrics Seed Round -
10/2006 Wilmington Pharmaceuticals Series B 0
9/2018 Roobrik Seed Round 0
3/2006 Affinergy Series B 3M
12/2014 Avhana Health Seed Round 0
12/2018 Tunnel Seed Round -
8/2014 Validic Series A 0
5/2014 Gemmus Pharma Series B 3.3M
6/2012 Gemmus Pharma Series A 1.8M
5/2011 OncoHealth Series A 1.6M
4/2015 Meta Seed Round 0
8/2007 Consolidated Asset Recovery Systems Series A 623k
10/2013 Chaologix Series C 1.5M
3/2007 Amulet Pharmaceuticals Series A 1.7M
1/2014 ABK Biomedical Angel Round -
12/2008 SpecMetrix Systems (Sensory Analytics) Convertible Note 0
6/2009 Pique Therapeutics Series A -
3/2009 Basho Technologies Series B 0
4/2009 Basho Technologies Series B 0
12/2018 Tunnel Seed Round -
9/2018 Roobrik Seed Round 0
4/2015 Meta Materials Seed Round 0
12/2014 Avhana Health Seed Round 0
8/2014 Validic Series A 0
5/2014 Gemmus Pharma Series B 0
5/2014 Trusted Metrics Seed Round -
1/2014 ABK Biomedical Angel Round -
10/2013 Chaologix Series C 0
6/2012 Gemmus Pharma Series A 0

Startup Industries

Startup Locations

Portfolio Current Status

Portfolio Employee Count

Name Price
Name Size Announced Date

You know, we could be doing all this for you..

CoBee's Logo

Be ahead of your competition

  • Realtime intelligence
  • Automated contact tracking
  • Unmatched insights
  • Eliminate manual research